This webinar explores France's governance of human biological samples for research, focusing on acquisition, storage, import/export, and unique requirements in comparison to global standards.
Local legislation surrounding the sourcing of human biospecimens for research varies greatly around the world. To provide valuable insights to researchers working with human biological samples (HBS), we're partnering up with global sourcing partners to highlight how different countries govern the sourcing process in our ongoing webinar series, "COMPLi HBS Legislation Series".
In this episode of the series, we highlight how France governs the recruitment, collection, storage, and import/export of human biological samples (HBS) for research.
Presenters
Caroline Rancati
Caroline Rancati graduated with a Master's degree in biobanking and the use of associated data. She has been working in this field for 4 years specializing in the management and coordination of projects that require the sourcing of HBS and/or associated data.
Pauline Mespoulhé
Pauline Mespoulhé is a biobank and health data expert specializing in the valorization of human biological samples and their integration into innovative research projects. She supports biotech, pharma, medtech, and academic teams in ensuring scientific, regulatory, and strategic alignment to strengthen project quality and impact.
Sponsor
France Tissue Bank
Content Partners
Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.
